Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers

Wound Repair and Regeneration

Volumn 8, Issue 1, 2000, Pages 13-25

  Trengove, Naomi J ^a   Bielefeldt Ohmann, Helle ^a,b   Stacey, Michael C ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; INFLAMMATION; LEG ULCER; MALE; MITOGENESIS; PRIORITY JOURNAL; TISSUE REPAIR; TISSUE WATER; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; CHRONIC DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; LEG ULCER; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 0034100341     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2000.00013.x     Document Type: Article

References (45)

1. Baker S, Stacey M, Jopp-McKay A, Hoskin S, Thompson P. Epidemiology of chronic venous ulcers. Br J Surg 1991;78:864-7.
2. Wilkinson LS, Bunker C, Edwards JCW, Scurr JH, Coleridge Smith PD. Leukocytes: Their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 1993;17:669-75.
3. Bjordal R. Flow and pressure studies in venous insufficiency. Acta Chir Scand 1988;544:30-3.
4. Burnand KG, Whimster I, Clemenson G, Thomas ML, Browse NL. The relationship between the number of capillaries in the skin of the venous ulcer-bearing area of the lower leg and the fall in foot vein pressure during exercise. Br J Surg 1981;68:297-300.
5. Fagrell B. Local microcirculation in chronic venous incompetence and leg ulcers. Vasc Surg 1979;13:217-25.
6. Clyne C, Ramsden W, Chant A, Webster J. Oxygen tension on the skin of the gaiter area of limbs with venous disease. Br J Surg 1985;72:644-7.
7. Bucalo B, Eaglstein W, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Rep Regen 1993;1:181-6.
8. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin deposition in the ulcer bearing skin of the lower limb: the cause of lipodermatosclerosis and venous ulceration. Br Med J 1982;295:1071-2.
9. Falanga V, Moosa H, Nemeth A, Alstadt S, Eaglstein W. Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol 1987;123:620-3.
10. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration: a new hypothesis. BMJ 1988;296: 1726-8.
11. Falanga V, Eaglstein W. The 'trap' hypothesis of venous ulceration. Lancet 1993;341:1006-7.
12. Davidson J, Buckley A, Woodward S, Nichols W, McGee G, Demetriou A. Mechanisms of accelerated wound repair using epidermal growth factor and basic fibroblast growth factor. In: Barbul A, Pines E, Caldwell M, Hunt T, editors. Growth factors and other aspects of wound healing: biological and clinical implications. New York: Alan R Liss, Inc., 1988:63-75.
13. Beck L, Deguzman L, Lee W, Xu Y, McFatridge L, Amento E. TGF-β accelerates wound healing: reversal of steroid-impaired healing in rats and rabbits. Growth Factors 1991;5:295-304.
14. Engray LH, Richey KJ, Kao CC, Murray MJ. Topical growth factors and wound contraction in the rat: Part II. Platelet derived growth factor and wound contraction in normal and steroid impaired rats. Ann Plas Surg 1989;23:245-8.
15. Lynch S, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989;84:640-6.
16. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butter EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986;204:322-30.
17. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective randomized trial of autologous platelet-derived wound healing factors for the treatment of chronic non-healing wounds: a preliminary report. J Vasc Surg 1991;14:526-36.
18. Robson MC, Phillips LG, Lawrence WT, Bishop JB, Youngerman JS, Hayward PG, Broemeling LD, Heggers JP. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 1992;216:401-8.
19. Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Derm Surg Oncol 1992; 18:604-6.
20. Hunt TK. Wound fluid: The growth environment. In: Barbul A, Caldwell M, Eaglestein WH, editors. Clinical and experimental approaches to dermal and epidermal repair: normal and chronic wounds. New York: Wiley-Liss, Inc., 1991:223-30.
21. Picardo M, Grey AM, McGurk M, Ellis I, Schor SL. Detection of migration stimulating activity in wound fluid. Exp Mol Pathol 1992;57:8-21.
22. Grayson LS, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA. Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 1993;19:401-5.
23. Wysocki AB, Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990;63:825-31.
24. Grinnell F, Zhu M. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol 1994;103:155-61.
25. Rasmussen LH, Jensen LT, Avnstorp C, Karlsmark T, Peters K, Horslev-Petersen K. Collagen types I and III propeptides as markers of healing in chronic leg ulcers. A noninvasive method for the determination of procollagen propeptides in wound fluid-influence of growth hormone. Ann Surg 1992;216:684-91.
26. Haukipuro K, Risteli L, Kairaluoma M, Risteli J. Aminoterminal propeptide of Type III Procollagen in healing wound in humans. Ann Surg 1987;206:752-6.
27. Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Rep Reg 1996;4:234-9.
28. Abramowitz HB, Queral LA, Flinn WR, Nora PG Jr, Peterson LK, Bergan JJ, Yao JS. The use of photoplethysmography in the assessment of venous insufficiency: a comparison to venous pressure measurements. Surgery 1979;86:434-41.
29. Jopp-McKay AG, Stacey MC, Rohr JB, Baker SR, Thompson PJ, Hoskin SE. Outpatient treatment of chronic venous ulcers in a specialised clinic. Aus J Dermatol 1991;32:143-9.
30. Yao ST, Hobbs JT, Irvine WT. Pulse examination by an ultrasonic method. Br Med J 1968;4(630):555-7.
31. Kaye J, Porcelli S, Tite J, Jones B, Janeway CA Jr. Both a monoclonal antibody and anti-sera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen presenting cells in the activation of T cells. J Exp Med 1983;158:836-56.
32. Mosmann T. Rapid colourimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63.
33. Helle M, Boeije L, Aarden LA. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 1988;18:1535-40.
34. Trengove NJ, Stacey MC. Quantitative bacteriology and chronic leg ulcer healing. In: Leaper D, Dealey C, Franks PJ, Hofman CJ, editors. Proceedings of the 7th European conference on advances in wound management. London: EMAP Healthcare Ltd, 1998: 77-81.
35. Harris IR, Yee KC, Walters CE, Cunliffe WJ, Kearney JN, Wood EJ, Ingham E. Cytokine and protease levels in healing and non-healing chronic leg ulcers. Exp Derm 1995;4:342-9.
36. Fivenson DP, Faria DT, Nickoloff BJ, Poverini PJ, Kunkel S, Burdick M, Strieter RM. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Rep Reg 1997;5:310-22.
37. Wallace HJ, Stacey MC. Levels of tumor necrosis factor alpha and soluble TNF receptors in chronic venous leg ulcers- correlations to healing status. J Invest Derm 1998;110:292-6.
38. Ono I, Gunji H, Suda K, Iwatsuki K, Kaneko F. Evaluation of cytokines in donor site wound fluids. Scand J Plastic Reconstr Surg Hand Surg 1994;28:269-73.
39. Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, Hisano S, Ogawa M. Elevation of circulating interleukin 6 after surgery: factors influencing serum levels. Cytokine 1994;6:181-6.
40. Saxne T, Zunio L, Heinegard D. Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis. Arth Rheum 1995;38:82-90.
41. Ito A, Sato T, Iga T, Mori Y. Tumour necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett 1990;269:93-5.
42. Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J, Docherty A. Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 1994;732:31-41.
43. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Derm 1996;107:743-8.
44. Wang HJ, Wan HL, Yang TS, Wang DS, Chen TM, Chang DM. Acceleration of skin graft healing by growth factors. Burns 1996;22:10-1.
45. Thalmann-Goetsch A, Engelmann K, Bednarz J. Comparative study on the effects of different growth factors on migration of bovine corneal endothelial cells during wound healing. Acta Opthamol Scand 1997;75:490-5.